Re-irradiation for recurrent glioblastoma: a pattern of care analysis
{{output}}
Background: 90% of glioblastomas (GBM) relapse within two years of diagnosis. In contrast to the initial setting, there is no standard management for recurrent disease and options include hypofractionated stereotactic re-irradiat... ...
